Skip to main content
BSF ENTERPRISE PLC logo

BSF ENTERPRISE PLC — Investor Relations & Filings

Ticker · BSFA ISIN · GB00BHNBDQ51 LEI · 2138007PJT69H8FYLC06 IL Professional, scientific and technical activities
Open in API
Filings indexed 171 across all filing types
Latest filing 2025-07-10 M&A Activity
Country GB United Kingdom
Listing IL BSFA

About BSF ENTERPRISE PLC

https://bsfenterprise.com/

BSF Enterprise PLC is a biotechnology company that develops and commercializes cell-based, tissue-engineered solutions. The company focuses on creating innovative materials and products for various applications, including cultivated meat, lab-grown leather, and technologies for corneal repair. The core business model involves acquiring and advancing proprietary technologies in cellular agriculture and regenerative medicine with the objective of licensing its intellectual property.

Recent filings

Filing Released Lang Actions
Agreement
M&A Activity Classification · 99% confidence The document is identified by the RNS Number (5222Q) and the header 'National Storage Mechanism', indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content announces a specific corporate event: 'Kerato signs Exclusive Worldwide Option Agreement' concerning intellectual property for a medical treatment. This is a material corporate development that is not a full financial report (like 10-K or IR), a management discussion (MDA), or a specific shareholder vote result (DVA). Since it is a general regulatory announcement that doesn't fit the highly specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory filing category, RNS.
2025-07-10 English
Interim 2025 Results
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Consolidated Financial Statements for the period ended 31 March 2025' and contains detailed financial summaries, a Chairman's Statement, a Chief Executive's Report, and business review highlights for the six-month period. It provides actual financial data (net loss, cash balances, loss per share) rather than just an announcement of a report. Therefore, it is classified as an Interim/Quarterly Report. H1 2025
2025-06-25 English
15p Warrants Amended
Capital/Financing Update Classification · 95% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text. The content details an amendment to the terms of previously issued warrants (reducing the exercise price and extending the term). This action directly relates to the company's capital structure and financing instruments. While it involves capital changes, the specific nature of amending existing debt/equity instruments like warrants often falls under Capital/Financing Update (CAP) or, given the RNS source and the nature of the announcement, it could be classified as a general Regulatory Filing (RNS) if a more specific code doesn't perfectly fit. However, since it is a direct announcement about changing the terms of warrants (a financing instrument), 'CAP' (Capital/Financing Update) is the most precise fit among the specific options, as it is not a general share issue (SHA) or a buyback (POS). Since it is a direct announcement of a material change to financing terms, CAP is appropriate. The document is short and is the primary announcement itself, not an announcement *about* a report, so RPA/RNS fallback is less preferred than the specific financial category.
2025-05-23 English
Lab-Grown Leather Ltd Progress
Regulatory Filings Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from BSF Enterprise PLC regarding operational progress in its subsidiary, Lab-Grown Leather Ltd. It details product development, technological breakthroughs, and commercial partnerships. Since it is a general regulatory announcement regarding company operations that does not fit into specific categories like financial reports, M&A, or dividends, it is classified as a Regulatory Filing (RNS).
2025-05-21 English
Strategic Investment
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from BSF Enterprise PLC regarding a conditional placement of 4,725,000 new ordinary shares to raise capital. This falls under the category of share issuance and capital changes, specifically matching the definition for 'Share Issue/Capital Change' (SHA).
2025-04-28 English
Joint Venture
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's Regulatory News Service (RNS). It announces a new partnership between BSF Enterprise PLC, VML, and The Organoid Company to develop 'T-Rex leather'. While it contains detailed information about the project, it is fundamentally a corporate announcement of a business development/partnership, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into more specific categories like M&A (which implies a change in ownership or control) or Earnings Release.
2025-04-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.